mediri GmbH

Studienstandort Deutschland – Packen wir es an! Unser Round Table widmet sich dieses Jahr auch dem Krankenhaus der Zukunft und der Frage, wie wir die klinische Forschung dort stärken können – immer mit dem Fokus auf den Patienten. Dabei sind Faktoren wie Ressourcen und Digitalisierung entscheidend, um dieses Ziel zu erreichen. Erfahren Sie mehr in der Diskussion mit Prof. Dr. Jochen A. Werner vom UNIVERSITATSKLINIKUM ESSEN ANSTALT DES OFFENTLICHEN RECHTS. #Medizinforschungsgesetz #standardvertragsklauseln #klinischeforschung #clinicalresearch #wefeelresponsible

Ich freue mich darauf, Sie im November auf dem BVMA Symposium in München zu treffen. Es erwartet uns eine spannende Zeit mit anregenden Diskussionen und persönlichem Austausch. Thematisch steht diesmal der Studienstandort Deutschland im Fokus, und wir werden neue Impulse für die klinische Forschung setzen. Bis bald in München! #mediri, #BVMASymposium, #München, #klinischeStudien

We are also looking forward to this collaboration with Tom Kirk and his team! We are excited about expanding our clinical trial services to reliable brain permeability measurements based on ASL.

Just imagine...you are planning a multi-center imaging study and you can choose whichever site you want irrespective of the MR scanner they have. In SIMAB, Fraunhofer MEVIS and mediri GmbH are developing a vendor-agnostic MR sequence development framework to increase the comparability of imaging biomarkers regardless of the employed scanner equipment. Structural imaging biomarkers as brain atrophy or lesions will be assessed as well as functional indicators of neurological diseases, e.g. brain perfusion or permeability. SIMAB is funded by the German Ministry for Research and Education.   #imagingbiomarker, #neurologic, #MRI, #mediri

October is Breast Cancer Awareness Month, an international effort to raise awareness about breast cancer prevention, research, and treatment. It highlights the crucial role of early detection and ongoing efforts to combat the disease. We’re proud to be part of the Marie-Sklodowska-Curie network BosomShield, which combines clinical, pathological, and radiological data to enhance breast cancer treatments. Our PhD students are currently working on AI-based lesion segmentation and classification on images of different modalities aiming for better relapse propability prediction. #breastcancer #mediri #radiology #bosomshield

Very important topic for the future of clinical research in Germany 🔬 🧫 🧬 🧪 💊 💉 🩻

🌍Tomorrow is World Alzheimer’s Day. This day emphasizes the importance of taking action at every stage of life to promote brain health and well-being. Alzheimer’s disease affects millions of people worldwide, including those living with the disease, as well as their families and caregivers. It is a journey full of challenges. At mediri, we support ASL measurements for the contrast free assessment of the blood brain barrier status after MR guided and focused ultrasound mediated BBB-opening in an Alzheimer therapy studies. Let’s work together to advocate for more research and better care options to improve the lives of those affected by Alzheimer’s.   #WorldAlzheimersDay #AlzheimersAwareness #BrainHealth

🎉 Celebrating 20 years of mediri GmbH! 🎉 Today, we are filled with joy and gratitude as we celebrate our 20th anniversary. Two decades of innovation, challenges, and successes are behind us. We are proud of what we have achieved together and extend our heartfelt thanks to our dedicated employees, loyal customers, and reliable partners for their support and trust. Looking to the future, we are ready to explore new paths and continue developing innovative solutions that drive us forward. Together, we will shape the next years of success 🚀 #Anniversary #20Years #mediri #Innovation #Gratitude

We proudly announce that our colleague Jürgen Jenne will present a poster on “Comparison of automated and manual tractography based tcMRgFUS therapy planning” at the ISTU Congress on Friday, September 20 in Taipei. Transcranial MR-guided focused ultrasound (tcMRgFUS) treatment for Essential Tremor and Parkinson's Tremor is becoming a clinical reality. While DTI tractography can enhance target identification, it is time-consuming, requiring multiple software programs and expert knowledge. The primary objective of the work presented is to streamline tractography-based therapy planning and make it accessible to all without specialized expertise.   The Project tcFUS-Control was supported by the Federal Ministry for Economic Affairs and Climate Action (BMWK) on the basis of a decision by the German Bundestag,ZF4173706CR9, ZF4801301CR9, ZF4178404CR9.   JJ@ISTU  https://lnkd.in/eQkzkUnQ General ISTU link https://lnkd.in/er6hjqzc  

We proudly announce that our project colleague Sven Rothlübbers from Fraunhofer MEVIS will present his results on “Fourier-based Signal Projection for Global Speed of Sound Autofocusing in Plane-Wave Imaging” at the ISTU Congress in Taipei on Sunday, September 22 at 09:34 AM in Session “Treatment Monitoring”. Information about the global speed of sound is a crucial basis for ultrasound therapy planning and monitoring. His work’s objective is to estimate it efficiently which will bring the AEGEUS project one step ahead. Sven@ISTU  https://lnkd.in/eQkzkUnQ General ISTU page https://lnkd.in/er6hjqzc